Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients

Haematologica. 2023 Nov 1;108(11):3152-3155. doi: 10.3324/haematol.2022.282478.
No abstract available

Publication types

  • Letter

MeSH terms

  • ADAMTS13 Protein
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic*
  • Purpura, Thrombotic Thrombocytopenic* / therapy
  • Recurrence
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • ADAMTS13 Protein